EntrepreneurialCheck
Robert Markelz estimated net worth profile

Robert Markelz net worth

Robert Markelz Net Worth 2026 (Estimated) · Vice President of Genomics at Rev Genomics · YC S17
est. wealth $8.0M

Quick answer

Robert Markelz's estimated net worth is $8.0M (range $5.6M – $12.0M) as of 2026. Robert Markelz is Vice President of Genomics at Rev Genomics. Rev Genomics valuation.

Robert Markelz is Vice President of Genomics at Rev Genomics (YC S17). Independent Entrepreneurial Check model estimate from public YC data.

At a glance

NameRobert Markelz
RoleVice President of Genomics
CompanyRev Genomics
YC batchS17
Est. company val$20.0M
Assumed ownership40%
Est. paper wealth / net worth$8.0M
$5.6M – $12.0M
  • Company status: Active
  • Region: United States of America
  • Industries: Healthcare, Diagnostics
  • Team size: 8
  • Website: https://www.revgenomics.com

Who is Robert Markelz?

Robert Markelz is a founder of Rev Genomics, a company that was part of Y Combinator's Summer 2017 cohort.

Highlights:

  • Y Combinator S17
  • Rev Genomics

About Rev Genomics

Rev Genomics is a plant biotechnology company that provides breeders, growers, and retailers with novel cultivars to differentiate themselves in high value markets.

FAQ: Robert Markelz net worth and Rev Genomics valuation

What is Robert Markelz's net worth?

Robert Markelz's estimated net worth is $8.0M (range $5.6M – $12.0M) as of 2026. Robert Markelz is Vice President of Genomics at Rev Genomics. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.

What is Rev Genomics valuation?

Rev Genomics's estimated valuation on Entrepreneurial Check is $20.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.

What is Robert Markelz's role?

Robert Markelz is Vice President of Genomics at Rev Genomics, a Y Combinator-backed startup (batch S17).